T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa by McMahon, WC, Kwatra, G, Izu, A, Koen, AL, Greffrath, J, Fairlie, L, Patel, F, Mukendi, CK, Mbele, NJ, Lala, R, Burgers, WA, Nunes, MC, Cutland, CL, Gilbert, SC, Lambe, T, Pollard, AJ, Madhi, SA

ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19 by Kaplonek, P, Cizmeci, D, Kwatra, G, Izu, A, Lee, JS-L, Bertera, HL, Fischinger, S, Mann, C, Amanat, F, Wang, W, Koen, AL, Fairlie, L, Cutland, CL, Ahmed, K, Dheda, K, Barnabas, SL, Bhorat, QE, Briner, C, Krammer, F, Saphire, EO, Gilbert, SC, Lambe, T, Pollard, AJ, Nunes, M, Wuhrer, M, Lauffenburger, DA, Madhi, SA, Alter, G

Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in Sou... by Koen, AL, Izu, A, Baillie, V, Kwatra, G, Cutland, CL, Fairlie, L, Padayachee, SD, Dheda, K, Barnabas, SL, Bhorat, QE, Briner, C, Ahmed, K, Bhikha, S, Bhiman, JN, du Plessis, J, Esmail, A, Horne, E, Hwa, S-H, Oommen-Jose, A, Lambe, T, Laubscher, M, Malahleha, M, Benade, G, McKenzie, S, Oelofse, S, Patel, F, Pillay, S, Rhead, S, Rodel, H, Taoushanis, C, Tegally, H, Thombrayil, A, Villafana, TL, Gilbert, S, Pollard, AJ, Madhi, SA

Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysi... by Madhi, SA, Kwatra, G, Richardson, SI, Koen, AL, Baillie, V, Cutland, CL, Fairlie, L, Padayachee, SD, Dheda, K, Barnabas, SL, Bhorat, QE, Briner, C, Ahmed, K, Aley, PK, Bhikha, S, Bhorat, AE, Esmail, A, Horne, E, Kaldine, H, Mukendi, CK, Madzorera, VS, Manamela, NP, Masilela, M, Hermanus, ST, Motlou, T, Mzindle, N, Oelofse, S, Patel, F, Rhead, S, Rossouw, L, Taoushanis, C, van Eck, S, Lambe, T, Gilbert, SC, Pollard, AJ, Moore, PL, Izu, A

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, do... by Madhi, SA, Koen, AL, Izu, A, Fairlie, L, Cutland, CL, Baillie, V, Padayachee, SD, Dheda, K, Barnabas, SL, Bhorat, QE, Briner, C, Aley, PK, Bhikha, S, Hermanus, T, Horne, E, Jose, A, Kgagudi, P, Lambe, T, Masenya, M, Masilela, M, Mkhize, N, Moultrie, A, Mukendi, CK, Moyo-Gwete, T, Nana, AJ, Nzimande, A, Patel, F, Rhead, S, Taoushanis, C, Thombrayil, A, van Eck, S, Voysey, M, Villafana, TL, Vekemans, J, Gilbert, SC, Pollard, AJ, Moore, PL, Kwatra, G

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK by Voysey, M, Clemens, SAC, Madhi, SA, Weckx, LY, Folegatti, PM, Aley, PK, Angus, B, Baillie, VL, Barnabas, SL, Bhorat, QE, Bibi, S, Briner, C, Cicconi, P, Collins, AM, Colin-Jones, R, Cutland, CL, Darton, TC, Dheda, K, Duncan, CJA, Emary, KRW, Ewer, KJ, Fairlie, L, Faust, SN, Feng, S, Ferreira, DM, Finn, A, Goodman, AL, Green, CM, Green, CA, Heath, PT, Hill, C, Hill, H, Hirsch, I, Hodgson, SHC, Izu, A, Jackson, S, Jenkin, D, Joe, CCD, Kerridge, S, Koen, A, Kwatra, G, Lazarus, R, Lawrie, AM, Lelliott, A, Libri, V, Lillie, PJ, Mallory, R, Mendes, AVA, Milan, EP, Minassian, AM, Lambe, T, Pollard, AJ

Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B.1.351 variant by Madhi, SA, Baillie, V, Cutland, CL, Voysey, M, Koen, AL, Fairlie, L, Padayachee, SD, Dheda, K, Barnabas, SL, Bhorat, QE, Briner, C, Kwatra, G, Ahmed, K, Aley, P, Bhikha, S, Bhiman, JN, Bhorat, AE, du Plessis, J, Esmail, A, Groenewald, M, Horne, E, Hwa, S-H, Jose, A, Lambe, T, Laubscher, M, Malahleha, M, Masenya, M, Masilela, M, McKenzie, S, Molapo, K, Moultrie, A, Oelofse, S, Patel, F, Pillay, S, Rhead, S, Rodel, H, Rossouw, L, Taoushanis, C, Tegally, H, Thombrayil, A, van Eck, S, Wibmer, CK, Durham, NM, Kelly, EJ, Villafana, TL, Gilbert, S, Pollard, AJ, de Oliveira, T, Moore, PL, Sigal, A, Izu, A

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses by Dejnirattisai, W, Huo, J, Zhou, D, Zahradník, J, Supasa, P, Liu, C, Duyvesteyn, HME, Ginn, HM, Mentzer, AJ, Tuekprakhon, A, Nutalai, R, Wang, B, Dijokaite, A, Khan, S, Avinoam, O, Bahar, M, Skelly, D, Adele, S, Johnson, SA, Amini, A, Ritter, TG, Mason, C, Dold, C, Pan, D, Assadi, S, Bellass, A, Omo-Dare, N, Koeckerling, D, Flaxman, A, Jenkin, D, Aley, PK, Voysey, M, Costa Clemens, SA, Naveca, FG, Nascimento, V, Nascimento, F, Fernandes da Costa, C, Resende, PC, Pauvolid-Correa, A, Siqueira, MM, Baillie, V, Serafin, N, Kwatra, G, Da Silva, K, Madhi, SA, Nunes, MC, Malik, T, Openshaw, PJM, Baillie, JK, Semple, MG, Dunachie, SJ, Lambe, T, Screaton, GR, Pollard, AJ